Drug: xeloda Quarter: 2016Q3
Total Drug/Injury Combinations: 457 Number of Pages: 23
DRUGNAME | PT | EventCount | |
---|---|---|---|
XELODA | Transaminases abnormal | 1 | view events |
XELODA | Transient ischaemic attack | 1 | view events |
XELODA | Transitional cell carcinoma | 1 | view events |
XELODA | Treatment failure | 1 | view events |
XELODA | Trismus | 1 | view events |
XELODA | Tumour lysis syndrome | 1 | view events |
XELODA | Unevaluable event | 1 | view events |
XELODA | Ureteric stenosis | 1 | view events |
XELODA | Urticaria | 1 | view events |
XELODA | Vasculitis | 1 | view events |
XELODA | Venous thrombosis | 1 | view events |
XELODA | Ventricular fibrillation | 1 | view events |
XELODA | Ventricular hypokinesia | 1 | view events |
XELODA | Vocal cord disorder | 1 | view events |
XELODA | Vocal cord paralysis | 1 | view events |
XELODA | White blood cell count abnormal | 1 | view events |
XELODA | Zinc deficiency | 1 | view events |
Total Drug/Injury Combinations: 457 Number of Pages: 23
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)